The sea of uncertainty surrounding ductal carcinoma in situ - The price of screening mammography

Journal of the National Cancer Institute

Volumn 100, Issue 4, 2008, Pages 228-229

  Welch, H Gilbert ^a,b,c   Woloshin, Steven ^a,b,c   Schwartz, Lisa M ^a,b,c  

^a VA MEDICAL CENTER   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ANXIETY; BREAST DUCT; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER INVASION; CANCER RISK; CANCER SCREENING; CARCINOMA IN SITU; EARLY DIAGNOSIS; EDITORIAL; HUMAN; LUNG CANCER; MAMMOGRAPHY; MELANOMA; NEUROBLASTOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROBABILITY; PROSTATE CANCER; STATISTICAL SIGNIFICANCE; THYROID CANCER; TUMOR BIOPSY; UNCERTAINTY; WATCHFUL WAITING; AUTOPSY; BIOPSY; BREAST TUMOR; FEMALE; HEALTH SURVEY; MASS SCREENING; NOTE; PAGET NIPPLE DISEASE; PALPATION; PATHOLOGY; RISK ASSESSMENT; RISK FACTOR;

AUTOPSY; BIOPSY; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; PALPATION; POPULATION SURVEILLANCE; RISK ASSESSMENT; RISK FACTORS; UNCERTAINTY;

EID: 39649086072     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djn013     Document Type: Editorial

References (22)

1. Eusebi V, Foschini MP, Cook MG, Berrino F, Azzopardi JG. Long-term follow-up of in situ carcinoma of the breast with special emphasis on clinging carcinoma. Semin Diagn Pathol. 1989;6(2):165-173.
2. Page D, Dupont W, Rogers L, Jensen R, Schuyler P. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer. 1995;76(7):1197-2000.
3. Welch HG, Black WC. Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: how much more breast cancer can we find? Ann Intern Med. 1997;127(11):1023-1028.
4. Hughes L, Wang M, Page D, et al. 5-year results of intergroup study E5194: local excision alone (without radiation treatment) for selected patients with ductal carcinoma in situ [abstract]. Breast Cancer Res Treat. 2006;100(Suppl 1): A-29, S15.
5. Partridge A, Adloff K, Blood E, et al. Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. J Natl Cancer Inst. 2008;100(4):243-251.
6. Mooi WJ, Peeper DS. Oncogene-induced cell senescence - halting on the road to cancer. N Engl J Med. 2006;355(10):1037-1046.
7. Folkman J, Kalluri R. Cancer without disease. Nature. 2004 ;427(6977):787.
8. Serrano M. Cancer regression by senescence. N Engl J Med. 2007;356(19):1996-1997.
9. Schilling FH, Spix C, Berthold F, et al. Neuroblastoma screening at one year of age. N Engl J Med. 2002;346(14):1047-1053.
10. Yamamoto K, Hanada R, Kikuchi A, et al. Spontaneous regression of localized neuroblastoma detected by mass screening. J Clin Oncol. 1998;16(4):1265-1269.
11. Welch HG, Woloshin S, Schwartz LM. Skin biopsy rates and incidence of melanoma: population based ecological study. BMJ. 2005;331(7515):481-484.
12. Davies L, Welch HG. The increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295(18):2164-2167.
13. Black WC. Overdiagnosis: an underrecognized cause of confusion and harm in cancer screening. J Natl Cancer Inst. 2000;92(16):1280-1282.
14. Etzioni R, Penson DF, Legler JM, et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst. 2002;94(13):981-990.
15. Zahl PH, Strand BH, Mæhlen J. Breast cancer incidence in Norway and Sweden during introduction of nation-wide screening: prospective cohort study. BMJ. 2004;328(7445):921-924.
16. Gotzsche P, Nielsen M. Screening for breast cancer with mammography [review]. Cochrane Database Syst Rev. 2006;4:CD001877.
17. Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP. Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study. BMJ. 2006;332(7543):689-692.
18. Welch HG, Schwartz LM, Woloshin S. Ramifications of screening for breast cancer: 1 in 4 cancers detected by mammography are pseudocancers. BMJ. 2006;332(7543):727.
19. Carter HB, Kettermann A, Warlick C, et al. Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience. J Urol. 2007;178(6):2359-2364.
20. Walsh PC, Deweese TL, Eisenberger MA. Localized prostate cancer. N Engl J Med. 2007;357(26):2696-2705.
21. http://www.cancer.gov/clinicaltrials/UCSF- 017513#ExpectedEnrollment_CDR0000465205 [Last accessed January 22, 2008].
22. Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst. 2000;92(18):1490-1499.